🔎 Trials Near Me

Hjem › Nyrekreft › Florida

Kliniske studier for Nyrekreft i Florida

14 studier for Nyrekreft søker deltakere på steder i Florida.

Byer i Florida

Offisiell studietekst (engelsk)

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

  • Research Site, Jacksonville
  • Research Site, Miami
  • Research Site, Orlando
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07011719

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04981119

NSAID Use After Robotic Partial Nephrectomy

  • University of Miami, Miami
RekruttererFase 2
Alder 18 til 99 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05842044

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Mayo Clinic Pharmacy, Jacksonville
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • og 1 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07227415

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Miami
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05536141

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Jacksonville
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT05433142

Integrated Cancer Repository for Cancer Research

  • Florida Hospital Memorial Medical Center, Daytona Beach
  • Florida Hospital DeLand, DeLand
  • Florida Hospital FISH, Orange City
  • og 2 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
  • Mayo Clinic Comprehensive Cancer Center, Jacksonville
  • Florida Cancer Specialists, Sarasota
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jun. 2026 · NCT06026410

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06239194

A Study of VET3-TGI in Patients With Solid Tumors

  • University of Miami, Miami
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 7. apr. 2026 · NCT06444815

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Miami Cancer Institute, Miami
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT06682793

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

  • Urological Research Network, Miami Lakes
Rekrutterer
Alder 55 til 65 · Alle kjønn · Oppdatert 26. jan. 2023 · NCT05218811

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.